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ta.2012.1Abstract We report a case of a 62-year old Indian female with a history of breast cancer treated
with surgery, chemotherapy and radiation three years ago, now presenting with diplopia on the
right eye for three weeks. CT showed a diffuse inﬁltrating lesion in the right cranial fossa. MRI
reported meningeal and orbital wall involvement also. The patient was referred for 18 FDG
PET/CT to assess the extent of disease and also to look for other distant metastases. 18 FDG
PET/CT revealed an exact extent of lesion, from the right orbital apex, destroying greater wall
of the sphenoid, extending to the nasopharynx and the right nasal cavity with extensive skeletal
metastases. We present symptoms, signs and imaging modalities that aided in localization of metas-
tases, while in the available literature such presentation of carcinoma breast secondaries in the naso-
pharynx is extremely rare.
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Allied Sciences.1. Introduction
Nasopharyngeal metastases from breast carcinoma is extre-
mely rare with only three cases previously reported in the liter-
ature.1–3 We present a case of breast cancer with distant
metastases to orbital apex, greater wing of the sphenoid and484 2852001; fax: +91 484
c.in (A. Tewari).
yptian Society of Ear, Nose,
g by Elsevier
ng by Elsevier B.V. on behalf of E
1.004extending to the nasopharynx with extensive skeletal metasta-
ses. We discuss the diagnostic role of whole body 18 FDG
PET/CT (18-Flourodeoxyglucose positron emission tomogra-
phy/computed tomography) to assess the extent of disease
and its implications in staging breast cancer and its
management.2. Case report
A 62-year old woman presented with a 3 weeks’ history of
blurring of vision and proptosis in the right eye. Three years
earlier the patient had been diagnosed with inﬁltrating ductal
carcinoma. The tumor was ER/PR positive and HER2-neu
negative. The initial treatment consisted of left mastectomy,
ﬂap reconstruction and neoadjuvant chemotherapy. Postoper-gyptian Society of Ear, Nose, Throat and Allied Sciences.
Figure 1 PET/CT (positron emission tomography), Transaxial images show no abnormal FDG uptake in the reconstructed left breast
ﬂap, right breast, bilateral internal mammary and axillary lymph nodes.
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ven. A whole body 18 FDG PET/CT to assess the therapy re-
sponse was done which was normal (Fig. 1), suggestive of a
good response to chemotherapy.
After three years, the patient complained of right sided dip-
lopia for 3 weeks. She was seen by an ophthalmologist who
diagnosed horizontal diplopia and abducent (VI) nerve palsy.
On clinical examination, the patient had right supraorbital
swelling and grade I proptosis with conjunctival injection or
papilloedema. CT of the head showed right orbital metastasis
with a tumor mass, a size of 3.7 · 4.2 · 2 cm, with inﬁltration
of the orbital roof and lateral orbital wall and greater wing of
the sphenoid (Fig. 2). MRI study further reported meningeal
and bony metastatic deposits involving the walls of the right
orbit (Fig. 3), middle and anterior cranial fossa with no asso-
ciated parenchymal brain lesion (Fig. 4). She underwent follow
up whole body 18 FDG PET/CT which revealed FDG avid
heterogeneously enhancing soft tissue lesion in right orbital
apex causing destruction of greater wing of the sphenoid,
lateral wall of orbit, right zygoma and extending to the naso-
pharynx and right nasal cavity (Fig. 5). Multiple metabolically
active skeletal metastases were also noted in C5 vertebra, right5th and 11th ribs, pelvic bones (bilateral iliac bones, inferior lip
of right acetabulum) and left femur (Fig. 6). She received an-
other course of chemotherapy and bisphosphonate treatment.
Local radiotherapy of the right orbit and the skull base is re-
served if there is further progression of symptoms.3. Discussion
Metastatic spread to nasal cavity, nasopharynx and hypophar-
ynx is extremely rare, and if it occurs, the primary site of
malignancy is usually a renal cell carcinoma.5 To our knowl-
edge, our case is the fourth case with nasopharyngeal involve-
ment from breast carcinoma and second as nasal cavity
involvement.1–3 The ﬁrst case presented as a choanal polyp,1
the second as a solitary nasal cavity metastasis,2 the third case
presented with diplopia and found to have partial nasal
obstruction on ENT examination only.3
Breast cancer metastases have a relatively wide distribution,
the most common sites of spread are bone, regional lymph
nodes, lung, liver and brain.4 Incidence of breast carcinoma
to head and neck is unknown, usually metastases of this region
Figure 2 Post contrast CT images showing enhancing lesion in
the right orbital apex extending laterally causing destruction of
greater wing of the sphenoid, lateral wall of orbit and zygoma.
Medially it extends to pharyngeal mucosal space and posterior
part of nasal cavity.
Figure 3 T1 weighted contrast MRI images showing enhancing
lesion involving walls of orbit.
Figure 4 T2 weighted coronal images showing meningeal and
bony metastastic lesion involving right anterior and middle cranial
fossa.
Figure 5 Follow up 18 FDG PET/CT revealed FDG avid
heterogeneously enhancing soft tissue lesion in the right orbital
apex causing destruction of greater wing of the sphenoid, lateral
wall of orbit, right zygoma and extending to the nasopharynx and
right nasal cavity.
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head and neck lesions usually remain occult. But now with
the wider availability of whole body 18 FDG PET/CT, we
can spotlight multiple obscured lesions from the head to toe.
Investigating nasopharyngeal lesions starts with clinical his-
tory and examination and includes tissue diagnosis via biopsy
and histopathological analysis. Computed tomography (CT) is
the initial radiological investigation of choice and should in-clude the thorax, abdomen and pelvis. MRI provides a better
delineation and higher resolution when there is need to inves-
tigate intracranial and soft tissue spread. 18 FDG PET/CT
Figure 6 18 FDG PET/CT MIP (maximum intensity projection)
images showing multiple metabolically active extensive skeletal
metastases in C5 vertebra, 5th and 11th right ribs, bilateral iliac
bones, inferior lip of right acetabulum and left femur.
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ing distant metastases.3 In some cases it may be necessary to
have one baseline 18 FDG PET/CT to assess the therapeutic re-
sponse and monitor treatment modiﬁcation in follow up.
So, when an ophthalmologist has a patient with unilateral
painful ophthalmopathy and proptosis, orbital metastases6
must be considered and detailed multidisciplinary team exam-
inations specially of the ENT should be performed,7 deﬁnitely
at the same time whole body 18 FDG PET/CT must be consid-
ered to correctly upstage or downstage the disease and to mod-
ify treatment plan.
Nasopharyngeal metastases respond well to radiation, some
tumors may be successfully treated with debulking or surgical
resection. Chemotherapy is usually needed for systemic dis-
ease. Recognizing metastatic disease and prompt early treat-
ment are very important to improve the quality of life.8.In summary, although rare, breast cancer patients can de-
velop metastases to the nasopharynx. Patients with a history
of breast cancer presenting with eye symptoms such as propto-
sis, diplopia, pain, exophthalmos should not only be evaluated
for orbital metastases but for nasopharyngeal involvement
also. Once the diagnosis is conﬁrmed, the treatment of naso-
pharyngeal metastases is multidisciplinary.
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